Cojocaru, G., Barbiro, I., Patel, M., Sharma, M., Shepard, D., Rasco, D., . . . Adewoye, A. H. (2023, November). 640 The combination of COM701 + nivolumab demonstrates preliminary antitumor activity in patients with metastatic breast cancer. Journal for ImmunoTherapy of Cancer.
Chicago Style (17th ed.) CitationCojocaru, Gady, et al. "640 The Combination of COM701 + Nivolumab Demonstrates Preliminary Antitumor Activity in Patients with Metastatic Breast Cancer." Journal for ImmunoTherapy of Cancer Nov. 2023.
MLA (9th ed.) CitationCojocaru, Gady, et al. "640 The Combination of COM701 + Nivolumab Demonstrates Preliminary Antitumor Activity in Patients with Metastatic Breast Cancer." Journal for ImmunoTherapy of Cancer, Nov. 2023.
Warning: These citations may not always be 100% accurate.